FDA Inspection 1148403 — Hisun Pharmaceutical Hangzhou Co., Ltd
The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on Jul 20, 2021 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 20, 2021
- Fiscal Year
- 2021
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)